(Q31103443)

28 June 2017

Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist (English)

1 reference

28 June 2017

1 reference

Tsutomu Yasukawa

1

1 reference

28 June 2017

Stefan Hoffmann

2

1 reference

28 June 2017

Wolfram Eichler

3

1 reference

28 June 2017

Ulrike Friedrichs

4

1 reference

28 June 2017

Yu-Sheng Wang

5

1 reference

28 June 2017

Peter Wiedemann

6

1 reference

28 June 2017

1 May 2004

1 reference

28 June 2017

1 reference

28 June 2017

28

1 reference

28 June 2017

5

1 reference

28 June 2017

359-366

1 reference

Submacular surgery. New information, more questions

28 June 2017

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Submacular surgery for choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Radiation therapy for ocular choroidal neovascularization (phase I/II study): preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Rapid isolation of choriocapillary endothelial cells by Lycopersicon esculentum-coated Dynabeads

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Biodegradable scleral plugs for vitreoretinal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Chorioretinal damage caused by the excision of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.28.5.359.28678

10.1076/CEYR.28.5.359.28678

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference